Gastroesophageal Junction Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. [NA]
A multicenter Phase II basket trial at Zhejiang Cancer Hospital is evaluating hypofractionated radiotherapy or SBRT followed by immunotherap…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression [Phase 2]
Phase 2 trial evaluating disitamab vedotin combined with tislelizumab and capecitabine as perioperative treatment for locally advanced, HER2…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients [Phase 2]
Phase 2 study evaluating second-line ramucirumab with or without paclitaxel in elderly patients with advanced gastric or gastroesophageal ju…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating FOLFIRI plus Durvalumab versus FOLFIRI plus Durvalumab and Tremelimumab as second-line treatment for …
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer [Phase 2]
A Phase 2 trial is evaluating AK104 with AK112 and SOX/XELOX chemotherapy as first-line treatment for advanced gastric and gastroesophageal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding Fruquintinib to Sintilimab and chemotherapy improves outcomes versus Sintilimab and ch…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating paclitaxel with apatinib and adebrelimab in gastric/gastroesophageal junction adenocarcinoma, currently re…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin [Phase 2]
A Phase 2 clinical trial is evaluating cadonilimab plus fruquintinib and paclitaxel-albumin as second-line therapy for advanced gastric/gast…
-
CLINICAL_TRIALS research · 2020-02-19Clinical Trial Update: Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical Study [Phase 2]
Phase 2 randomized study evaluating concurrent neoadjuvant chemoradiotherapy with trastuzumab for HER-2 positive gastroesophageal junction a…
-
CLINICAL_TRIALS research · 2018-03-02Clinical Trial Update: The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal [Phase 2]
A Phase 2 clinical trial update for conversion therapy using the FLOT regimen in adenocarcinoma of the stomach and gastroesophageal junction…
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma [Phase 2, Phase 3]
This document reports an update on a Phase 2/Phase 3 clinical trial evaluating preoperative concurrent chemoradiotherapy for locally advance…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update on MBP-426 for second-line gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, and esophageal adenocarci…
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach [Phase 3]
Phase 3 intergroup trial evaluating adjuvant chemotherapy for stomach and gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2012-03-15Clinical Trial Update: Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating tesetaxel as second-line therapy for advanced gastric cancer, including gastric and gastroesophageal junct…
-
CLINICAL_TRIALS research · 2008-10-21Clinical Trial Update: Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase II neoadjuvant trial of docetaxel (Taxotere), cisplatin, and 5-fluorouracil for gastric or gastroesophageal junction adenocarcinoma; n…